211 related articles for article (PubMed ID: 21336257)
1. Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase.
Hosoda N; Funakoshi Y; Hirasawa M; Yamagishi R; Asano Y; Miyagawa R; Ogami K; Tsujimoto M; Hoshino S
EMBO J; 2011 Apr; 30(7):1311-23. PubMed ID: 21336257
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB.
Ogami K; Hosoda N; Funakoshi Y; Hoshino S
Oncogene; 2014 Jan; 33(1):55-64. PubMed ID: 23178487
[TBL] [Abstract][Full Text] [Related]
3. Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation.
Ruan L; Osawa M; Hosoda N; Imai S; Machiyama A; Katada T; Hoshino S; Shimada I
J Biol Chem; 2010 Sep; 285(36):27624-31. PubMed ID: 20595394
[TBL] [Abstract][Full Text] [Related]
4. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.
Ezzeddine N; Chang TC; Zhu W; Yamashita A; Chen CY; Zhong Z; Yamashita Y; Zheng D; Shyu AB
Mol Cell Biol; 2007 Nov; 27(22):7791-801. PubMed ID: 17785442
[TBL] [Abstract][Full Text] [Related]
5. Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities.
Ezzeddine N; Chen CY; Shyu AB
Mol Cell Biol; 2012 Mar; 32(6):1089-98. PubMed ID: 22252318
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylases.
Funakoshi Y; Doi Y; Hosoda N; Uchida N; Osawa M; Shimada I; Tsujimoto M; Suzuki T; Katada T; Hoshino S
Genes Dev; 2007 Dec; 21(23):3135-48. PubMed ID: 18056425
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.
Horiuchi M; Takeuchi K; Noda N; Muroya N; Suzuki T; Nakamura T; Kawamura-Tsuzuku J; Takahasi K; Yamamoto T; Inagaki F
J Biol Chem; 2009 May; 284(19):13244-55. PubMed ID: 19276069
[TBL] [Abstract][Full Text] [Related]
8. Arsenite inhibits mRNA deadenylation through proteolytic degradation of Tob and Pan3.
Yamagishi R; Hosoda N; Hoshino S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):323-31. PubMed ID: 25446091
[TBL] [Abstract][Full Text] [Related]
9. A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation.
Amine H; Ripin N; Sharma S; Stoecklin G; Allain FH; Séraphin B; Mauxion F
RNA Biol; 2021 Dec; 18(12):2450-2465. PubMed ID: 34060423
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 accelerates deadenylation of target mRNAs by recruiting Caf1 deadenylase.
Fukushima M; Hosoda N; Chifu K; Hoshino SI
FEBS Lett; 2019 Feb; 593(3):277-287. PubMed ID: 30520513
[TBL] [Abstract][Full Text] [Related]
11. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.
Marchese FP; Aubareda A; Tudor C; Saklatvala J; Clark AR; Dean JL
J Biol Chem; 2010 Sep; 285(36):27590-600. PubMed ID: 20595389
[TBL] [Abstract][Full Text] [Related]
12. Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex.
Miyasaka T; Morita M; Ito K; Suzuki T; Fukuda H; Takeda S; Inoue J; Semba K; Yamamoto T
Cancer Sci; 2008 Apr; 99(4):755-61. PubMed ID: 18377426
[TBL] [Abstract][Full Text] [Related]
13. BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation.
Stupfler B; Birck C; Séraphin B; Mauxion F
Nat Commun; 2016 Feb; 7():10811. PubMed ID: 26912148
[TBL] [Abstract][Full Text] [Related]
14. The BTG2 protein is a general activator of mRNA deadenylation.
Mauxion F; Faux C; Séraphin B
EMBO J; 2008 Apr; 27(7):1039-48. PubMed ID: 18337750
[TBL] [Abstract][Full Text] [Related]
15. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
16. The mammalian anti-proliferative BTG/Tob protein family.
Winkler GS
J Cell Physiol; 2010 Jan; 222(1):66-72. PubMed ID: 19746446
[TBL] [Abstract][Full Text] [Related]
17. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control.
Okochi K; Suzuki T; Inoue J; Matsuda S; Yamamoto T
Genes Cells; 2005 Feb; 10(2):151-63. PubMed ID: 15676026
[TBL] [Abstract][Full Text] [Related]
18. BTG/TOB factors impact deadenylases.
Mauxion F; Chen CY; Séraphin B; Shyu AB
Trends Biochem Sci; 2009 Dec; 34(12):640-7. PubMed ID: 19828319
[TBL] [Abstract][Full Text] [Related]
19. The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.
Maryati M; Airhihen B; Winkler GS
Biochem J; 2015 Jul; 469(1):169-76. PubMed ID: 25944446
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional Stabilization of Ucp1 mRNA Protects Mice from Diet-Induced Obesity.
Takahashi A; Adachi S; Morita M; Tokumasu M; Natsume T; Suzuki T; Yamamoto T
Cell Rep; 2015 Dec; 13(12):2756-67. PubMed ID: 26711342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
